Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)
TWD 14.45
(1.76%)
TWD 14.45
(1.76%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.25 Million TWD | -121.24% |
| 2022 | 10.6 Million TWD | 109.92% |
| 2021 | -106.91 Million TWD | -61.49% |
| 2020 | -66.2 Million TWD | 57.28% |
| 2019 | -154.97 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.9 Million TWD | -111.48% |
| 2024 Q2 | -1.9 Million TWD | 0.0% |
| 2023 FY | -2.25 Million TWD | -121.24% |
| 2023 Q4 | 16.57 Million TWD | 0.0% |
| 2023 Q3 | 16.57 Million TWD | 207.92% |
| 2023 Q1 | -15.36 Million TWD | -536.66% |
| 2023 Q2 | -15.36 Million TWD | 0.0% |
| 2022 Q4 | -2.41 Million TWD | 0.0% |
| 2022 FY | 10.6 Million TWD | 109.92% |
| 2022 Q3 | -2.41 Million TWD | 0.0% |
| 2021 FY | -106.91 Million TWD | -61.49% |
| 2020 FY | -66.2 Million TWD | 57.28% |
| 2019 FY | -154.97 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 100.799% |
| Level Biotechnology Inc. | 67.55 Million TWD | 103.335% |
| Sagittarius Life Science Corp | -64.37 Million TWD | 96.5% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 97.348% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 99.017% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 97.349% |
| Visgeneer Inc. | -21.15 Million TWD | 89.352% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 100.252% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 102.792% |
| Neith Corporation | -48.85 Million TWD | 95.388% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | 65.915% |
| Enimmune corporation | -243.47 Million TWD | 99.075% |
| TaiRx, Inc. | -214.69 Million TWD | 98.951% |
| EirGenix Inc. | -1.03 Billion TWD | 99.782% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 103.557% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | 96.875% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 97.586% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 98.724% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 109.325% |
| Lukas Biomedical Inc. | -43.56 Million TWD | 94.828% |
| RBC Bioscience Corporation | 14.53 Million TWD | 115.496% |
| BiOptic Inc. | 44.05 Million TWD | 105.114% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | 96.03% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | 96.406% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 96.577% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 100.674% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 99.626% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 99.814% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | 96.808% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 98.645% |
| GlycoNex Incorporation | -259.86 Million TWD | 99.133% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | 95.049% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 99.795% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 99.675% |
| VBI | -16.13 Million TWD | 86.034% |
| CHO Pharma, Inc. | -268.99 Million TWD | 99.162% |
| NaviFUS Corp. | -76.42 Million TWD | 97.052% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 97.602% |
| Sinew Pharma Inc. | -186.25 Million TWD | 98.79% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 96.672% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 101.41% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 99.4% |
| AP Biosciences Inc | -347.47 Million TWD | 99.352% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 99.817% |
| 3D Global Biotech Inc. | -62.85 Million TWD | 96.415% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | 20.22% |
| Intech Biopharm Corporation | -304.39 Million TWD | 99.26% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 99.795% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | 94.569% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 98.671% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 100.667% |
| TCI GENE Inc. | 10.04 Million TWD | 122.42% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 98.23% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 99.276% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 98.938% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 165.609% |
| PharmaEngine, Inc. | 277.18 Million TWD | 100.813% |
| Savior Lifetec Corporation | -2.42 Million TWD | 6.901% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 98.71% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 99.892% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 98.171% |
| Acepodia, Inc. | -435.97 Million TWD | 99.483% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 99.538% |